Should you perform total body skin exams on patients to screen for skin cancer in patients using topical ruxolitinib?
Featuring Tina Bhutani, MD, MAS | CEO, Synergy Dermatology Associate Clinical Professor of Dermatology University of California, SF San Francisco, CA | Published February 15, 2023
Related Media
Powered by Polaris TM